Recombinant human insulin-like growth factor-1 therapy for 6 months improves growth but not motor function in boys with Duchenne muscular dystrophy.
Muscle Nerve
; 61(5): 623-631, 2020 05.
Article
in En
| MEDLINE
| ID: mdl-32108355
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Body Height
/
Recombinant Proteins
/
Insulin Resistance
/
Insulin-Like Growth Factor I
/
Growth Substances
/
Muscular Dystrophy, Duchenne
/
Muscle Strength
Type of study:
Clinical_trials
Limits:
Child
/
Humans
/
Male
Language:
En
Journal:
Muscle Nerve
Year:
2020
Type:
Article
Affiliation country:
United States